Maricopa County (Arizona) Drug Court is a postadjudication program for probationers with a first-time felony conviction for drug possession. Probationers are required to participate in an outpatient comprehensive drug treatment program, and their progress is monitored by the judge.
In this June 9th, 2017 congressional briefing, Beau Kilmer, codirector of the RAND Drug Policy Research Center, provides an overview of recent changes in marijuana policies as well as options for the federal government.
The report sets out the findings of an evaluation that assesses the degree of implementation of the EU Drugs Strategy 2013-2020 and the Action Plan 2013-2016 in all 28 EU Member States in terms of outputs and, where possible, impacts.
Data lags and the elimination of the ADAM program complicate estimates of U.S. cocaine consumption. New users who haven't yet developed cocaine dependence are also a factor. It may be prudent to start planning for an increase in heavy use even before all of the evidence is in.
After recreational marijuana laws were passed, perceived harm associated with marijuana use decreased among students in 8th and 10th grades in Washington state and use increased; neither perception nor use changed in Colorado after legalization.
Transnational criminal networks have expanded their global reach. In some cases, they have even converged with terrorist groups. How do these networks threaten U.S. interests? And what can be done to combat them?
This publication is part of a series of four RAND Perspectives (PE) each focusing on different challenges in the Mediterranean region. The focus of this PE is on defence and security issues and their implications for regional stability.
There are many ways to legalize marijuana supply besides the for-profit approach. But to learn what effects various models have, the federal government will have to make it easier for states to implement some middle-ground options.
This tool reviews how primary care providers should discuss and treat alcohol or opioid dependence with their patients, including using extended-release, injectable naltrexone and administering buprenorphine/naloxone.
In this Call with the Experts, Beau Kilmer, codirector of the RAND Drug Policy Research Center, discusses the controversy surrounding marijuana policy and highlights issues policymakers and voters should consider before making their decisions.
Co-occurring psychiatric symptoms and either or both drug dependence or heavy drinking among people with HIV can reduce their quality of life and interfere with treatment adherence; therefore HIV service providers should screen for these conditions and provide appropriate services.
Crime, violence, substance misuse and illicit markets harm communities across Europe. RAND Europe helps decisionmakers at national and pan-European levels assess threats and identify and develop policies to improve safety, security and other outcomes.
A mandatory public consultation was conducted to inform the Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and the final evaluation of the EU Action Plan on Drugs 2013-2016. This document reports on the consultation's results.
About 70 percent of a community sample of young veterans reported screening positive for behavioral health conditions, with co-occurrence of many conditions, but only about one-third received minimally adequate care.
Vendors in the Netherlands have developed a fairly successful international trade of ecstasy-type drugs and stimulants from online markets, but it appears that most countries are selling illicit drugs within their own borders.
A motivational interviewing approach that targets social networks to reduce risky behavior was found to be helpful in a focus group of residents and staff of Housing First, a permanent supportive housing organization for formerly homeless people.
This study aims to map alternatives to coercive sanctions (ACS) for drug law offences and drug-related crimes that are available under the law in each EU member state and describe the use of these sanctions in practice.
Harmonizing measurement of drug policy indicators, such as prevalence of use, problematic use, and drug enforcement, would help improve cross-national comparisons of how nations deal with illicit drugs.